References

  1. Ermakov IV, et al. Optical Assessment of Skin Carotenoid Status as a Biomarker of Vegetable and Fruit Intake. Arch Biochem Biophys. 2018 May 15;646:46-54. 

  2. Conrady, C.D., et al. Correlations Between Macular, Skin, and Serum Carotenoids. Invest. Ophthalmol. Vis. Sci. 2017;58(9):3616-3627.

  3. Caparello G, et al. Association between Skin Carotenoid Score Measured with Veggie Meter* and Adherence to the Mediterranean Diet among Adolescents from Southern Italy. Nutrients. 2023 Nov25;15(23):4920.

  4. Toh DWK, et al. Skin Carotenoids Status as a Potential Surrogate Marker for Cardiovascular Disease Risk Determination in Middle-Aged and Older Adults. Nutr Metab Cardiovasc Dis. 2021 Feb 8;31(2):592-601.

  5. Mrowicka, M, et al. Lutein and Zeaxanthin and their Role in Age-Related Macular Degeneration – Neurodegenerative Disease. Nutrition. 2022 Feb 16; 14(4):827.

  6. Maoka, T. Carotenoids as natural Functional Pigments. J Nat Med. 2020; 74:1-16.

  7. Lee, E.H., et al. Dietary Lutein Reduces Ultraviolet Radiation-Induced Inflammation and Immunosuppression. J Investig Dermatol. 2004, 122:510-517.

  8. Lem DW, Davey PG, Gierhart DL, Rosen RB. A Systematic Review of Carotenoids in the Management of Age-Related Macular Degeneration. Antioxidants (Basel). 2021 Aug 5;10(8):1255.

  9. Arunkumar R, et al. What Do We Know about the Macular Pigment in AMD: the Past, the Present, and the Future. Eye. 2018; 32:992-1004.

  10. Sommerburg O, Keunen JE, Bird AC, van Kuijk FJ. Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol. 1998;82:907–10.

  11. Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: The Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 2013, 309, 2005–2015.

  12. Nagai N, Minami S, Suzuki M, Shinoda H, Kurihara T, Sonobe H, Watanabe K, Uchida A, Ban N, Tsubota K, et al. Macular Pigment Optical Density and Photoreceptor Outer Segment Length as Predisease Biomarkers for Age-Related Macular Degeneration. Journal of Clinical Medicine. 2020; 9(5):1347.

  13. Obana A, et al. Macular Carotenoid Levels of Normal Subjects and Age-Related Maculopathy Patients in a Japanese Population. Ophthalmol. 2008; 115(1):147-157.

  14. Huang, Y.M, et al.. Effect of supplemental lutein and zeaxanthin on serum, macular pigmentation, and visual performance in patients with early age-related macular degeneration. Biomed. Res. Int. 2015. 2015, article ID 564738.

  15. Ma, L., et al. Lutein and zeaxanthin intake and the risk of age-related macular degeneration: A systematic review and meta-analysis. Br. J. Nutr. 2012. 107, 350–359.

  16. Seddon JM, et al. Dietary Carotenoids, Vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA. 1994 Nov 9; 272(18):1413-1420.

  17. Mares JA, et al. Healthy Lifestyles Related to Subsequent Prevalence of Age-Related Macular Degeneration. Arch Ophthalmol. 2011 Apr; 129(4): 470-780.

  18. Meyers, K.J.; Johnson, E.J.; Bernstein, P.S.; Iyengar, S.K.; Engelman, C.D.; Karki, C.K.; Liu, Z.; Igo, R.P., Jr.; Truitt, B.; Klein, M.L.; et al. Genetic determinants of macular pigments in women of the Carotenoids in Age-Related Eye Disease Study. Investig. Ophthalmol. Vis. Sci. 2013. 54: 2333–2345.

  19. Age-Related Eye Disease Study Research Group; SanGiovanni, JP; et al. The Relationship of Dietary Carotenoid and vitamin A, E, and C Intake with Age-Related Macular Degeneration in a Case-Control Study: AREDS Report No. 22. Arch. Ophthalmol. 2007. 125:1225–1232. 

  20. Age-Related Eye Disease Study 2 Research Group; Chew, EY, et al. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report no. 3. JAMA Ophthalmol. 2014. 132:142–14.

  21. Wu, J MS, et al. Intakes of Lutein, Zeaxanthin and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-Up. JAMA Ophthalmol. 2015. 133(12):1415-1424.

  22. Liu, R, et al.. Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2014, 56:252–258.

  23. Nolan JM, et al. Nutritional Intervention to Prevent Alzheimer’s Disease: Potential Benefits of Xanthophyll Carotenoids and Omega-3 Fatty Acids Combined. Journal of Alzheimer’s disease. 2018, 64(2): 367-378.

  24. Crupi P, et al. Overview of the Potential Beneficial Effects of Carotenoids on Consume Health and Well-Being. Antioxidants (Basel). 2023 May. 12(5): 1069.

  25. Wang Y, et al. Dietary carotenoids are associated with cardiovascular disease risk biomarkers mediated by serum carotenoid concentrations. Journal of Nutrition and Disease. 2014 Jul; 144(7):1067-1074.

  26. Takayanagi Y, et al. Relationships between Skin Carotenoid Levels and Metabolic Syndrome. Antioxidants (Basel). 2021 Dec; 11(1):14.

  27. Mullan K, et al. Plasma antioxidant status in patients with Alzheimer’s disease and cognitively intact elderly: A meta-analysis of case-control studies. Journal of Alzheimer’s Disease, 2018. 62(1): 305-317.

  28. Ha K, et al. Dietary Total Antioxidant Capacity, a Diet Quality Index Predicting Mortality Risk in US Adults: Evidence from the NIH-AARP Diet and Health Study. Antioxidants (Basel). 2023 May; 12(5): 1086.

     

  29. Bone RA, Landrum JT, Cains A. Optical density spectra of the macular pigment in vivo and in vitro. Vis Res. 1992;32:105–110.